These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 20696223)
21. Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal. Aher S; Dhumal R; Mahadik K; Ketolainen J; Paradkar A Pharm Dev Technol; 2013 Feb; 18(1):55-60. PubMed ID: 21981663 [TBL] [Abstract][Full Text] [Related]
22. High-shear granulation as a manufacturing method for cocrystal granules. Rehder S; Christensen NP; Rantanen J; Rades T; Leopold CS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1019-30. PubMed ID: 23685353 [TBL] [Abstract][Full Text] [Related]
23. Mechanistic Insight into Caffeine-Oxalic Cocrystal Dissociation in Formulations: Role of Excipients. Duggirala NK; Vyas A; Krzyzaniak JF; Arora KK; Suryanarayanan R Mol Pharm; 2017 Nov; 14(11):3879-3887. PubMed ID: 28990387 [TBL] [Abstract][Full Text] [Related]
24. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals. Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596 [TBL] [Abstract][Full Text] [Related]
25. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346 [TBL] [Abstract][Full Text] [Related]
26. Green production of cocrystals using a new solvent-free approach by spray congealing. Duarte Í; Andrade R; Pinto JF; Temtem M Int J Pharm; 2016 Jun; 506(1-2):68-78. PubMed ID: 27073084 [TBL] [Abstract][Full Text] [Related]
27. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid. Aher S; Dhumal R; Mahadik K; Paradkar A; York P Eur J Pharm Sci; 2010 Dec; 41(5):597-602. PubMed ID: 20801215 [TBL] [Abstract][Full Text] [Related]
29. Characterization of drug-cyclodextrin formulations using Raman mapping and multivariate curve resolution. Vajna B; Farkas I; Farkas A; Pataki H; Nagy Z; Madarász J; Marosi G J Pharm Biomed Anal; 2011 Aug; 56(1):38-44. PubMed ID: 21628088 [TBL] [Abstract][Full Text] [Related]
30. Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy. Cassidy AM; Gardner CE; Jones W Int J Pharm; 2009 Sep; 379(1):59-66. PubMed ID: 19539735 [TBL] [Abstract][Full Text] [Related]
31. Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying. Patil SP; Modi SR; Bansal AK Eur J Pharm Sci; 2014 Oct; 62():251-7. PubMed ID: 24931188 [TBL] [Abstract][Full Text] [Related]
32. Vibrational Spectroscopy for Cocrystals Screening. A Comparative Study. Rodrigues M; Lopes J; Sarraguça M Molecules; 2018 Dec; 23(12):. PubMed ID: 30544751 [TBL] [Abstract][Full Text] [Related]
33. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals. Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850 [TBL] [Abstract][Full Text] [Related]
34. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of a Glibenclamide Cocrystal: Full Spectroscopic and Thermal Characterization. Silva Filho SF; Pereira AC; Sarraguça JMG; Sarraguça MC; Lopes J; Façanha Filho PF; Dos Santos AO; da Silva Ribeiro PR J Pharm Sci; 2018 Jun; 107(6):1597-1604. PubMed ID: 29432762 [TBL] [Abstract][Full Text] [Related]
36. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment. Koranne S; Sahoo A; Krzyzaniak JF; Luthra S; Arora KK; Suryanarayanan R Mol Pharm; 2018 Aug; 15(8):3297-3307. PubMed ID: 29947519 [TBL] [Abstract][Full Text] [Related]
37. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture. Padrela L; de Azevedo EG; Velaga SP Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083 [TBL] [Abstract][Full Text] [Related]
38. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. Elder DP; Holm R; Diego HL Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973 [TBL] [Abstract][Full Text] [Related]
39. Detection of trace crystallinity in an amorphous system using Raman microscopy and chemometric analysis. Widjaja E; Kanaujia P; Lau G; Ng WK; Garland M; Saal C; Hanefeld A; Fischbach M; Maio M; Tan RB Eur J Pharm Sci; 2011 Jan; 42(1-2):45-54. PubMed ID: 20969956 [TBL] [Abstract][Full Text] [Related]
40. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process. Zhang GC; Lin HL; Lin SY J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]